Jeff Sharman (@jeff_sharman) 's Twitter Profile
Jeff Sharman

@jeff_sharman

Harvard/Stanford trained community practice Heme/Onc - Director of Hematology Research US Oncology - challenging white collar traditions with blue collar moxie

ID: 1532384084

linkhttps://www.linkedin.com/in/jeff-sharman-m-d-811ab71b/ calendar_today20-06-2013 00:26:36

1,1K Tweet

2,2K Followers

748 Following

Journal of Clinical Oncology (@jco_asco) 's Twitter Profile Photo
Journal of Clinical Oncology
@jco_asco

2 months ago

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321) brnw.ch/21wTktH Jeff Sharman #leusm #lymsm

Daniel Auclair (@auclairdan) 's Twitter Profile Photo
Daniel Auclair
@auclairdan

2 months ago

Dr. John Burke on mosunetuzumab MorningSun study, TN MZL cohort at #EHA2025 . ORR of 77.8%, CMR 63.9% with 18.2 mo median FU. Safety and CRS manageable, supports further exploration #lymsm

Dr. John Burke on mosunetuzumab MorningSun study, TN MZL cohort at #EHA2025 . ORR of 77.8%, CMR 63.9% with 18.2 mo median FU. Safety and CRS manageable, supports further exploration #lymsm
Jeff Sharman (@jeff_sharman) 's Twitter Profile Photo
Jeff Sharman
@jeff_sharman

2 months ago

Secret swimming holes in the cascades. Perfect for a Father’s Day afternoon